FLUORESCENCE LIFETIME PATTERNS IN MACULAR TELANGIECTASIA TYPE 2.

"The authors received nonfinancial support from Heidelberg Engineering GmBH, Germany."

"This prospective, cross-sectional study was conducted at the University Hospital in Bern, Switzerland, with the approval of the local ethics committee. The study was performed in accordance with International Conference on Harmonisation-Good Clinical Practice (ICH-GCP) guidelines, which correspond to the Health Insurance Portability and Accountability Act of 1996 (HIPAA) regulations, which is in accordance with the Declaration of Helsinki. This study is registered at ClinicalTrials.gov (NCT01981148). All patients and healthy controls were recruited at the Ophthalmology outpatient department of the University Hospital, Bern, Switzerland. An informed consent was signed before study entry."